Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Dermavant sells Tapinarof commercial rights in Japan

pharmaceutical-technologyJanuary 19, 2020

Tag: Dermavant , Tapinarof , psoriasis , atopic dermatitis

PharmaSources Customer Service